Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment
Status:
Terminated
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
This is a research study to determine if administering carboplatin at a slower rate when
re-treating recurrent ovarian cancer patients prior to the development of a hypersensitivity
reaction will decrease the frequency and severity of future hypersensitivity reactions.